FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078807 [Registered on: 31/12/2024] Trial Registered Prospectively
Last Modified On: 20/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani
Other (Specify) [Amal-e-Kai]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Treatment of Sciatica by Amal-e-kai(Cauterisation) 
Scientific Title of Study   Efficacy of Amal-e-kai in alleviating the pain of irqunnasa- A randomised controlled clinical trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Dwarakeesha Chatrappa 
Designation  PG Scholar 
Affiliation  National Institute of Unani Medicine, Bangalore 
Address  Department of Ilaj bit Tadbeer, National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore

Bangalore
KARNATAKA
560091
India 
Phone  6363181751  
Fax    
Email  dwarakish2016@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Mohd Nayab 
Designation  Associate Professor 
Affiliation  National Institute of Unani Medicine, Bangalore 
Address  Department OF Ilaj bit Tadbeer, National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore

Bangalore
KARNATAKA
560091
India 
Phone  9019080556  
Fax    
Email  nayabdr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Mohd Nayab 
Designation  Associate Professor 
Affiliation  National Institute of Unani Medicine, Bangalore 
Address  Department OF Ilaj bit Tadbeer, National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore

Bangalore
KARNATAKA
560091
India 
Phone  9019080556  
Fax    
Email  nayabdr@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Unani Medicine Magadi main road Kottigepalya Bangalore 560091 Karnataka 
 
Primary Sponsor  
Name  National Institute of Unani Medicine 
Address  NATIONAL INSTITUTE OF UNANI MEDICINE, MAGADI MAIN ROAD, KOTTIGEPALYA, BANGALORE 560091 KARNATAKA INDIA 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Dwarakeesha Chatrappa  National Institute of Unani Medicine, Bangalore  OPD 28, Department of Ilaj bit Tadbeer, National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bangalore-560091
Bangalore
KARNATAKA 
6363181751

dwarakish2016@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Communication of Decision of the Institutional Ethics Committe (IEC) for Biomedical Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G00-G99||Diseases of the nervous system, (2) ICD-10 Condition: G544||Lumbosacral root disorders, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Amal-e-Kai  In test group, to make the patient comfortable in prone position and the amal-e-kai is done in four points along the course of the respective sciatic nerve viz, over the hip joint postero-laterally, just above the knee joint line postero-laterally, 4cm above the lateral malleolus and lateral aspect of the little toe, done on 1st, 8th and 15th day(3 sittings in 15days) 
Comparator Agent  TENS(Transcutaneous Electrical Nerve Stimulation)  in control group TENS is done over lower back and course of sciatic nerve over 20mins of duration on 1st, 8th and 15th day(3 sittings in 15days) 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.clinically diagnosed patients if sciatica
2.patient having pain in range of 3 to 7 on VAS
3.patient willing to take part in the study 
 
ExclusionCriteria 
Details  1.pregnant and lactating women
2.systemic illness such as cancer, DM, epilepsy,
cardiac, liver, kidney and pulmonary diseases
3.Spinal injury and deformity(congenital/acquired)
4.who fail to give consent for trial 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
VAS(VISUAL ANALOGUE SCALE)  At baseline, 2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
SBI(Sciatica Bothersomeness Index)  At baseline, 2 weeks 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Purpose- Efficacy of Amal-e-Kai in alleviating the pain of Irqunnasa(Sciatica)- A randomised controlled clinical trial

Intervention- In test group, to make the patient comfortable in prone position and the amal-e-kai is done in four points along the course of the respective sciatic nerve viz, over the hip joint postero-laterally, just above the knee joint line postero-laterally, 4cm above the lateral malleolus and lateral aspect of the little toe, done on 1st, 8th and 15th day(3 sittings in 15days)
control- In control group TENS is done over lower back and course of sciatic nerve over 20mins of duration on 1st, 8th and 15th day(3 sittings in 15days)

Study duration: 1year 6months

Main outcome measure:

Primary outcome: VAS (Visual Analogue Scale)

Secondary outcome: SBI (Sciatica Bothersomeness Index)

 
Close